Comparison
Abducens Nerve Neoplasm C1263898 vs 15q11q13 Microduplication Syndrome C2675336
Clinical comparison between Abducens Nerve Neoplasm and 15q11q13 Microduplication Syndrome for differential diagnosis and treatment planning.
Abducens Nerve Neoplasm C1263898
A tumor of the 6th cranial nerve that controls eye movement. Can affect anyone. Treated with surgery or radiation.
15q11q13 Microduplication Syndrome C2675336
A genetic disorder involving duplication of material from the chromosome 15 region linked to Prader-Willi and Angelman syndromes. Features may include developmental delays, learning difficulties, and sometimes autism spectrum traits. Supportive therapies help manage symptoms.
6 comparison axes
Onset
Abducens Nerve Neoplasm C1263898
Variable
15q11q13 Microduplication Syndrome C2675336
0-3
Onset patterns differ
Severity
Abducens Nerve Neoplasm C1263898
severe
15q11q13 Microduplication Syndrome C2675336
moderate
Different severity levels
Chronic
Abducens Nerve Neoplasm C1263898
Chronic
15q11q13 Microduplication Syndrome C2675336
Chronic
Differing course
Communicable
Abducens Nerve Neoplasm C1263898
No
15q11q13 Microduplication Syndrome C2675336
No
Different transmission
Body System
Abducens Nerve Neoplasm C1263898
neurologic
15q11q13 Microduplication Syndrome C2675336
congenital
Same/different system
Category
Abducens Nerve Neoplasm C1263898
oncology
15q11q13 Microduplication Syndrome C2675336
genetic
Different category
Bottom line
abducens-nerve-neoplasm-C1263898 and 15q11q13-microduplication-syndrome-C2675336 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | Abducens Nerve Neoplasm C1263898 | 15q11q13 Microduplication Syndrome C2675336 | Discriminating power |
|---|---|---|---|
| Eye movement | May affect sixth-nerve control of eye movement; specific findings are not established here. | Eye-movement abnormality is not described in the supplied source. | Moderate |
| Development | Developmental delay is not part of the supplied description. | May include developmental delay, learning difficulty, and sometimes autism-spectrum traits. | High |
| Onset pattern | Onset is listed as variable. | Onset is listed as ages 0–3 years. | Moderate |
When to favor each condition
Choose Abducens Nerve Neoplasm C1263898 when
Focal neurologic concern
Choose when evaluation concerns a possible tumor of the sixth cranial nerve.
High
Acquired eye-movement problem
The supplied description centers on nerve control of eye movement rather than a congenital syndrome.
Moderate
Oncology pathway
The category is oncology, with surgery or radiation mentioned as treatment options.
Moderate
Choose 15q11q13 Microduplication Syndrome C2675336 when
Early developmental concern
Choose when congenital features and developmental or learning difficulties are the main issue.
High
Suspected chromosomal duplication
The source specifically describes duplication of chromosome 15q11q13 material.
High
Supportive-care planning
Management is described as supportive therapies rather than tumor-directed treatment.
Moderate
How key tests differ
| Test | Abducens Nerve Neoplasm C1263898 | 15q11q13 Microduplication Syndrome C2675336 | Interpretation |
|---|---|---|---|
| Neuroimaging | May be used to evaluate a suspected cranial-nerve tumor; results are not specified. | Not established by the supplied source as the defining test. | Imaging does not by itself prove either diagnosis. |
| Chromosomal microarray or genetic testing | No genetic test result is supplied for this neoplasm. | May identify duplication involving 15q11q13 when clinically indicated. | A genetic result requires laboratory and clinician confirmation. |
| Neuro-ophthalmic examination | May assess sixth-nerve-related eye movement; exact findings are not established. | No characteristic eye finding is supplied. | Examination findings should be interpreted in full clinical context. |
Prognosis comparison
Abducens Nerve Neoplasm C1263898
- Outcome
- Prognosis is not established in the supplied data.
- Factors
- Listed as severe and chronic; tumor type, location, and treatment response are unspecified.
15q11q13 Microduplication Syndrome C2675336
- Outcome
- Long-term outcome is not established; features may be managed supportively.
- Factors
- Listed as moderate and chronic, with variable developmental and learning effects.
Time frame: No reliable time frame is supplied.
Individual course, exact diagnosis, and response to care require clinician interpretation.
Complications comparison
| Complication | Presentation |
|---|---|
| Neurologic impairment | Potential impact relates to sixth-nerve function; extent is not quantified. May involve developmental and learning difficulties. Neither complication profile is fully established from the source. |
| Treatment-related burden | Surgery or radiation may be considered, with risks determined individually. Supportive therapies are described; no procedure-specific risks are supplied. Do not infer doses, outcomes, or complication rates. |
| Associated neurodevelopmental features | Not described in the supplied neoplasm summary. Autism-spectrum traits may occur in some people. Presence and severity vary and require clinical assessment. |
Patient education highlights
- HighDifferent conditions
A cranial-nerve tumor and a chromosomal microduplication have different causes and evaluation pathways.
- HighNo self-diagnosis
An abnormal finding or suspected feature is not a confirmed diagnosis without clinician review.
- MediumCare planning
Ask about appropriate imaging, genetic testing, supportive therapy, and specialist referral.